Á lódáil...
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy
Targeting the amyloid‐β (Aβ) peptide cascade has been at the heart of therapeutic developments in Alzheimer's disease (AD) research for more than 25 years, yet no successful drugs have reached the marketplace based on this hypothesis. Nevertheless, the genetic and other evidence remains strong,...
Na minha lista:
| Foilsithe in: | Br J Pharmacol |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley and Sons Inc.
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6715594/ https://ncbi.nlm.nih.gov/pubmed/30710367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14593 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|